Griptha Putra Persada Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Griptha Putra Persada Tbk. trades at Rp137 (market cap 132B, 126.63M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 3.2× Griptha Putra Persada Tbk.'s market cap, and Griptha Putra Persada Tbk. is more actively traded (126.63M versus 13.83M). Which is the better fit depends on your goals.
| GRPH | PRDL | |
|---|---|---|
Market Cap | 132B | 428.75B |
Volume | 126.63M | 13.83M |
Lot | 1.27M | 138.27K |
Turnover | — | 3.27B |
Average Price | — | 236.62 |
Value | — | 3.27B |
Indicative Equilibrium Price | — | 236 |
Indicative Equilibrium Volume | — | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Read more on GRPH →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →